DNA test for tracking colorectal cancer treatment response
Part of Cancer, Digestive system clinical trials.
This trial uses a blood test to track changes in cancer-related DNA markers (methylation) to see how well treatment is working. It is for people with colorectal or small intestinal cancer that has not spread and who have not yet started treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were 18 to 75 years old when first diagnosed with colorectal or small intestinal cancer.
- Your cancer has not spread to distant organs like the liver or lungs.
- You have not had surgery, chemotherapy, or immunotherapy for this cancer yet.
- You have not had any other type of cancer before.
- You are expected to live at least 6 more months, and you are able to make your own decisions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how gene changes called methylation can help doctors track how well treatment is working for gastric cancer. If you are newly diagnosed and have not had surgery or chemotherapy yet, you may be able to join.
This trial checks a blood test for “ctDNA methylation” to see who may be at higher risk of colorectal cancer returning after surgery. It may help doctors better judge whether adjuvant chemotherapy is working or needed.
This study is testing whether a blood test that looks for tiny bits of tumor DNA (ctDNA methylation) can help monitor how well treatment is working in people with colorectal cancer that has spread. If you are getting radiation and chemotherapy (with or without an immunotherapy drug), this trial may help your doctor see if the treatment is working sooner.
This study checks a special blood test (circulating tumor DNA methylation) to help guide follow-up after surgery for non-metastatic colon cancer. It may help find whether additional treatment or closer monitoring is needed based on the test results.
This study uses a blood test to check for tumor DNA after surgery, which may help doctors decide if you need additional chemotherapy. It is for people with stage 3 colorectal cancer that is removed by surgery.
This study is testing a new way to detect colorectal cancer early by looking for specific changes (gene methylation) in stool and blood samples. If you are 40 or older and have a colonoscopy scheduled, this non-invasive approach might help find cancer sooner.
Hear when a new Intestinal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.